Characterization of kaposiform lymphangiomatosis tissue‐derived cells
- 29 April 2021
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 68 (10) , e29086
Abstract
Background: Kaposiform lymphangiomatosis (KLA) is a recently characterized systemic lymphatic anomaly. Activation of RAS/MAPK and PI3K/AKT/mTOR pathways may affect KLA pathogenesis, but the cellular basis of KLA is unclear. Abnormal‐spindle endothelial cells that express lymphatic endothelial cell (LEC) markers are characteristic of KLA histopathology. This study evaluated patient‐derived KLA cells to establish their morphological and biological characteristics.Procedure: We established cell lines from primary KLA tissues of two patients with KLA and examined their morphological and functional characteristics, messenger RNA and protein expression profiles, gene mutations, and responses to inhibitors of the RAS/MAPK and PI3K/AKT/mTOR pathways.Results: Both KLA cell lines showed spindle‐shaped morphology, stained positive for podoplanin (PDPN), and exhibited impaired tube‐formation properties. They expressed LEC marker PDPN and mesenchymal stem cell markers (CD90, CD105) in the absence of endothelial cell markers (CD34, CD31, VWF), per real‐time polymerase chain reaction. Both mTOR inhibitor rapamycin and MEK inhibitor trametinib inhibited growth of the two cell lines. A NRAS p.Q61R variant was found in one of two independent KLA tissue samples, but not in the KLA cells (per targeted next‐generation sequencing); and KLA cells with this variant had elevated AKT phosphorylation levels. ERK phosphorylation levels were undetectable in both KLA cell lines.Conclusions: Inhibition of the RAS/MAPK and PI3K/AKT/mTOR pathways may represent potential therapeutic targets in KLA. These patient‐derived KLA cell lines will be useful research tools to elucidate KLA etiology, and could pave the way for basic, translational, and preclinical studies of this disease.Keywords
This publication has 21 references indexed in Scilit:
- Direct-Puncture Lymphatic Embolization in the Prone Position for Chylothorax Caused by Lymphatic AnomalyJournal of Vascular and Interventional Radiology, 2020
- Detection of NRAS mutation in cell-free DNA biological fluids from patients with kaposiform lymphangiomatosisOrphanet Journal of Rare Diseases, 2019
- Kaposiform lymphangiomatosis and kaposiform hemangioendothelioma: similarities and differencesOrphanet Journal of Rare Diseases, 2019
- Signaling pathways and inhibitors of cells from patients with kaposiform lymphangiomatosisPediatric Blood & Cancer, 2019
- A somatic activating NRAS variant associated with kaposiform lymphangiomatosisGenetics in Medicine, 2018
- Proliferative Cells From Kaposiform Lymphangiomatosis Lesions Resemble Mesenchyme Stem Cell–like Pericytes Defective in Vessel FormationJournal of Pediatric Hematology/Oncology, 2018
- Clinical Features and Prognosis of Generalized Lymphatic Anomaly, Kaposiform Lymphangiomatosis, and Gorham-Stout DiseasePediatric Blood & Cancer, 2016
- Kaposiform lymphangiomatosis: Unifying features of a heterogeneous disorderPediatric Blood & Cancer, 2014
- Kaposiform Lymphangiomatosis: A Distinct Aggressive Lymphatic AnomalyThe Journal of Pediatrics, 2014
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001